342 related articles for article (PubMed ID: 18942710)
1. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
[TBL] [Abstract][Full Text] [Related]
2. Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells.
Wehner R; Bitterlich A; Meyer N; Kloß A; Schäkel K; Bachmann M; Schmitz M
Int J Cancer; 2013 Mar; 132(6):1351-9. PubMed ID: 22907335
[TBL] [Abstract][Full Text] [Related]
3. TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.
Tufa DM; Chatterjee D; Low HZ; Schmidt RE; Jacobs R
Eur J Immunol; 2014 Dec; 44(12):3717-28. PubMed ID: 25229755
[TBL] [Abstract][Full Text] [Related]
4. Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3.
Costantini C; Calzetti F; Perbellini O; Micheletti A; Scarponi C; Lonardi S; Pelletier M; Schakel K; Pizzolo G; Facchetti F; Vermi W; Albanesi C; Cassatella MA
Blood; 2011 Feb; 117(5):1677-86. PubMed ID: 21098395
[TBL] [Abstract][Full Text] [Related]
5. The bidirectional crosstalk between human dendritic cells and natural killer cells.
Wehner R; Dietze K; Bachmann M; Schmitz M
J Innate Immun; 2011; 3(3):258-63. PubMed ID: 21411969
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells.
Straube C; Wehner R; Wendisch M; Bornhäuser M; Bachmann M; Rieber EP; Schmitz M
Leukemia; 2007 Jul; 21(7):1464-71. PubMed ID: 17495970
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
Gerner M; Hölig K; Wehner R; Zhao S; Schäkel K; Bachmann MP; Rieber EP; Bornhäuser M; Schmitz M
Transplantation; 2009 Apr; 87(8):1134-9. PubMed ID: 19384158
[TBL] [Abstract][Full Text] [Related]
8. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.
Jinushi M; Takehara T; Kanto T; Tatsumi T; Groh V; Spies T; Miyagi T; Suzuki T; Sasaki Y; Hayashi N
J Immunol; 2003 Feb; 170(3):1249-56. PubMed ID: 12538683
[TBL] [Abstract][Full Text] [Related]
9. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.
Gerosa F; Gobbi A; Zorzi P; Burg S; Briere F; Carra G; Trinchieri G
J Immunol; 2005 Jan; 174(2):727-34. PubMed ID: 15634892
[TBL] [Abstract][Full Text] [Related]
10. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
[TBL] [Abstract][Full Text] [Related]
11. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.
Toma M; Wehner R; Kloß A; Hübner L; Fodelianaki G; Erdmann K; Füssel S; Zastrow S; Meinhardt M; Seliger B; Brech D; Noessner E; Tonn T; Schäkel K; Bornhäuser M; Bachmann MP; Wirth MP; Baretton G; Schmitz M
Oncoimmunology; 2015 Jun; 4(6):e1008342. PubMed ID: 26155414
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
Mager K; Wehner R; Bahr F; Oelschlägel U; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Radke J; Röllig C; Schetelig J; Thiede C; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
Transplantation; 2012 Jun; 93(12):1270-5. PubMed ID: 22643330
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils promote 6-sulfo LacNAc+ dendritic cell (slanDC) survival.
Micheletti A; Costantini C; Calzetti F; Camuesco D; Costa S; Tamassia N; Cassatella MA
J Leukoc Biol; 2013 Oct; 94(4):705-10. PubMed ID: 23559493
[TBL] [Abstract][Full Text] [Related]
15. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells.
Wehner R; Wehrum D; Bornhäuser M; Zhao S; Schäkel K; Bachmann MP; Platzbecker U; Ehninger G; Rieber EP; Schmitz M
Haematologica; 2009 Aug; 94(8):1151-6. PubMed ID: 19546436
[TBL] [Abstract][Full Text] [Related]
18. ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation.
Marongiu L; Donini M; Toffali L; Zenaro E; Dusi S
PLoS One; 2013; 8(10):e75684. PubMed ID: 24130733
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
[TBL] [Abstract][Full Text] [Related]
20. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
Repnik U; Bergant M; Wraber B; Jeras M
Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
